Industry: Pharmaceuticals, Biotechnology
Chronogen Inc., a privately-held drug discovery company, is a leader in the identification of targets that control the degenerative processes of aging. Based on this innovative approach, the company is developing novel products to control lipid and oxidative stress levels, which are established disease mechanisms in cardiovascular disorders. The control of aging in whole model organisms has provided very valuable assets for a drug discovery technology that will lead to novel and efficacious drugs in significant markets including atherosclerosis, vascular complications of diabetes, and ischemia/reperfusion injuries. Chronogen is headquartered in Montreal, Canada. ( www.chronogen.com )
Chronogen Inc.
2901 Rachel E. Suite 22
Montreal, Quebec H1W 4A4
Canada
Tel: (514) 521-9595
Fax: (514) 521-1579